skip to content »

Translational Biology & Molecular Medicine

Houston, Texas

Benchtop, Research, Bedside and Application
Translational Biology & Molecular Medicine Graduate Program
not shown on screen

Kevin M. Slawin, M.D.

Kevin M. Slawin, M.D.Clinical Professor
Department of Urology

Phone: 713-798-8670
Fax: 713-798-4950


  • Columbia College of Physicians and Surgeons, New York, NY
  • Mount Sinai Hospital, New York, NY
  • Columbia-Presbyterian Medical Center, New York, NY
  • Baylor College of Medicine, Houston, TX

Research Interests

  • Urologic oncology
  • Diseases of the prostate
  • Quality of life outcomes

Clinical Focus

  • Prostrate cancer

Selected Publications

  • Sonpavde G, Slawin KM, Spencer, DM, Levitt JM. Emerging vaccine therapy approaches for prostate cancer. Reviews in Urology. In press.
  • Svatek RS, Jeldres C, Karakiewicz PI, Suardi N, Walz J, Roehrborn CG, Montorsi F, Slawin KM, Shariat SF. Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence. Prostate. 2009. 69(8):886-94.
  • Mullins C, Lucia MS, Hayward SW, Lee JY, Levitt JM, Lin VK, Liu BC, Chinnaiyan AM, Rubin MA, Slawin K, Star RA, Getzenberg RH; MPSA Consortium. A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium. J Urol. 2008. 179(4):1243-56.
  • Shariat SF, Karam JA, Walz J, Roehrborn CG, Montorsi F, Margulis V, Saad F, Slawin KM, Karakiewicz PI. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Clin Cancer Res. 2008. 14(12):3785-91.
  • Svatek RS, Karam JA, Roehrborn CG, Karakiewicz PI, Slawin KM, Shariat SF. Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy. Clin Cancer Res. 2008. 14(11):3362-6.
  • Trabulsi EJ, Valicenti RK, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Lin DW, Anscher MS, Slawin KM, Roehrborn CG, Forman JD, Liauw SL, Kestin LL, Deweese TL, Scardino PT, Stephenson AJ, Pollack A. A Multi-Institutional Matched-Control Analysis of Adjuvant and Salvage Postoperative Radiation Therapy for pT3-4N0 Prostate Cancer. Urology. 2008. 72(6):1298-302; discussion 1302-4.
  • Levitt JM, Slawin KM. Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression. Curr Urol Rep. 2007. 8(4):269-74. Review.

E-mail this page to a friend